tiprankstipranks
Trending News
More News >
MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ:MIRA
US Market

MIRA Pharmaceuticals, Inc. (MIRA) Income Statement

Compare
289 Followers

MIRA Pharmaceuticals, Inc. Income Statement

Last quarter (Q3 2025), MIRA Pharmaceuticals, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, MIRA Pharmaceuticals, Inc.'s net income was $-22.69M. See MIRA Pharmaceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 8.02M$ 8.53M$ 7.05M$ 2.15M$ 67.63K
Depreciation and Amortization
$ -2.00$ 0.00$ 7.05M$ 2.15M$ 0.00
EBITDA
$ -8.02M$ -8.53M$ 0.00$ 0.00$ -67.63K
Operating Income
$ -8.02M$ -8.53M$ -7.05M$ -2.15M$ -67.63K
Other Income/Expenses
$ 165.67K$ -3.46M$ -10.25K$ -24.37K$ -364.00
Pretax Income
$ -7.85M$ -11.98M$ -7.06M$ -2.18M$ -67.99K
Net Income
$ -7.85M$ -11.98M$ -7.06M$ -2.18M$ -67.99K
Per Share Metrics
Basic EPS
$ -0.51$ -0.65$ -0.48$ -0.15$ 0.00
Diluted EPS
$ -0.51$ -0.65$ -0.48$ -0.15$ 0.00
Weighted Average Shares Outstanding
15.44M 18.57M 14.75M 14.75M 14.75M
Weighted Average Shares Outstanding (Diluted)
15.44M 18.57M 14.75M 14.75M 14.75M
Currency in USD

MIRA Pharmaceuticals, Inc. Earnings and Revenue History